The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1

Animals Mice Alarmins / metabolism CD8-Positive T-Lymphocytes Interleukin-1 Receptor-Like 1 Protein / metabolism Interleukin-33 / metabolism Lymphocytic Choriomeningitis / immunology Lymphocytic choriomeningitis virus Mice, Inbred C57BL Persistent Infection T Cell Transcription Factor 1 / metabolism
CD8(+)SL IL-33 T cell factor 1 Tcf-1 chronic viral infection interleukin-33 lymphocytic choriomeningitis virus stem-like CD8(+) T cells type I interferon

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
11 04 2023
Historique:
received: 11 08 2022
revised: 22 12 2022
accepted: 27 01 2023
medline: 14 4 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

T cell factor 1 (Tcf-1) expressing CD8

Identifiants

DOI: 10.1016/j.immuni.2023.01.029 PMID: 36809763
pubmed: 36809763
pii: S1074-7613(23)00041-9
doi: 10.1016/j.immuni.2023.01.029
pii:
doi:

Substances chimiques

Alarmins 0
Interleukin-1 Receptor-Like 1 Protein 0
Interleukin-33 0
T Cell Transcription Factor 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

813-828.e10

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests D.D.P. is a founder, consultant, and shareholder of Hookipa Pharma Inc. commercializing arenavirus-based vector technology, and he as well as W.V.B., S.M.K., and D.M. are listed as inventor on corresponding patents.

Auteurs

Anna-Friederike Marx (AF)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland. Electronic address: a.marx@unibas.ch.

Sandra M Kallert (SM)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Tobias M Brunner (TM)

Experimental Immunology and Osteoarthritis Research, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany; Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center (DRFZ), a Leibniz Institute, 10117 Berlin, Germany.

José A Villegas (JA)

Department of Immunobiology, University of Lausanne, 1066 Epalinges, Switzerland.

Florian Geier (F)

Department of Biomedicine, Bioinformatics Core Facility, University Hospital Basel, 4031 Basel, Switzerland; Swiss Institute of Bioinformatics, Basel, Switzerland.

Jonas Fixemer (J)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Tiago Abreu-Mota (T)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Peter Reuther (P)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Weldy V Bonilla (WV)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Jelizaveta Fadejeva (J)

Experimental Immunology and Osteoarthritis Research, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany; Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center (DRFZ), a Leibniz Institute, 10117 Berlin, Germany.

Mario Kreutzfeldt (M)

Department of Pathology and Immunology University of Geneva, Geneva, Switzerland; Division of Clinical Pathology, Geneva University Hospital, 1211 Geneva, Switzerland.

Ingrid Wagner (I)

Department of Pathology and Immunology University of Geneva, Geneva, Switzerland; Division of Clinical Pathology, Geneva University Hospital, 1211 Geneva, Switzerland.

Patricia Aparicio-Domingo (P)

Department of Immunobiology, University of Lausanne, 1066 Epalinges, Switzerland.

Leo Scarpellino (L)

Department of Immunobiology, University of Lausanne, 1066 Epalinges, Switzerland.

Mélanie Charmoy (M)

Department of Oncology, University of Lausanne, 1066 Epalinges, Switzerland.

Daniel T Utzschneider (DT)

Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia.

Claudia Hagedorn (C)

Witten/Herdecke University (UW/H), Faculty of Health/School of Medicine, Stockumer Str. 10, 58453 Witten, Germany.

Min Lu (M)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Karen Cornille (K)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Karsten Stauffer (K)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland.

Florian Kreppel (F)

Witten/Herdecke University (UW/H), Faculty of Health/School of Medicine, Stockumer Str. 10, 58453 Witten, Germany.

Doron Merkler (D)

Department of Pathology and Immunology University of Geneva, Geneva, Switzerland; Division of Clinical Pathology, Geneva University Hospital, 1211 Geneva, Switzerland.

Dietmar Zehn (D)

Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, 85354 Freising, Germany.

Werner Held (W)

Department of Oncology, University of Lausanne, 1066 Epalinges, Switzerland.

Sanjiv A Luther (SA)

Department of Immunobiology, University of Lausanne, 1066 Epalinges, Switzerland.

Max Löhning (M)

Experimental Immunology and Osteoarthritis Research, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany; Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center (DRFZ), a Leibniz Institute, 10117 Berlin, Germany. Electronic address: max.loehning@charite.de.

Daniel D Pinschewer (DD)

Department of Biomedicine, Division of Experimental Virology, University of Basel, 4055 Basel, Switzerland. Electronic address: daniel.pinschewer@unibas.ch.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Alarmines › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Récepteurs aux cytokines › Récepteurs aux interleukines › Récepteurs à l'interleukine-1 › Protéine-1 analogue au récepteur de l'interleukin-1 › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-33 › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Maladies du système nerveux › Méningite › Méningite virale › Chorioméningite lymphocytaire › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Arenaviridae › Arenavirus › Arénavirus de l'Ancien Monde › Virus de la chorioméningite lymphocytaire › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Infection persistante › The alarmin interleukin-33 promotes the...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription TCF › Facteur de transcription TCF-1 › The alarmin interleukin-33 promotes the...